SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,000 | -88.2% | 81,891 | -55.4% | 0.00% | -100.0% |
| Q3 2021 | $820,000 | -49.2% | 183,451 | -38.1% | 0.00% | -57.1% |
| Q2 2021 | $1,615,000 | +220.4% | 296,405 | +538.5% | 0.01% | +133.3% |
| Q4 2020 | $504,000 | +93.1% | 46,423 | +89.8% | 0.00% | +50.0% |
| Q2 2020 | $261,000 | +53.5% | 24,458 | +86.7% | 0.00% | -71.4% |
| Q1 2018 | $170,000 | – | 13,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |